AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases
- Nature. 2024 Sep 25. doi: 10.1038/s41586-024-07992-y.
- 1. Life Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of the Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
- 2. Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, Hangzhou City University School of Medicine, Hangzhou, China.
- 3. Institutes of Biology and Medical Science, Soochow University, Suzhou, China.
- 4. The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- 5. Life Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of the Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China. [email protected].
- 6. The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. [email protected].
- 7. Cancer Center, Zhejiang University, Hangzhou, China. [email protected].
L-lactate modifies proteins through lactylation1, but how this process occurs is unclear. Here we identify the alanyl-tRNA synthetases AARS1 and AARS2 (AARS1/2) as intracellular L-lactate sensors required for L-lactate to stimulate the lysine lactylome in cells. AARS1/2 and the evolutionarily conserved Escherichia coli orthologue AlaRS bind to L-lactate with micromolar affinity and they directly catalyse L-lactate for ATP-dependent lactylation on the lysine acceptor end. In response to L-lactate, AARS2 associates with Cyclic GMP-AMP Synthase (cGAS) and mediates its lactylation and inactivation in cells and in mice. By establishing a genetic code expansion orthogonal system for lactyl-lysine incorporation, we demonstrate that the presence of a lactyl moiety at a specific cGAS amino-terminal site abolishes cGAS liquid-like phase separation and DNA sensing in vitro and in vivo. A lactyl mimetic knock-in inhibits cGAS, whereas a lactyl-resistant knock-in protects mice against innate immune evasion induced through high levels of L-lactate. MCT1 blockade inhibits cGAS lactylation in stressed mice and restores innate immune surveillance, which in turn antagonizes viral replication. Thus, AARS1/2 are conserved intracellular L-lactate sensors and have an essential role as lactyltransferases. Moreover, a chemical reaction process of lactylation targets and inactivates cGAS.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Topoisomerase; ADC Payloads; AMPK; Autophagy; Apoptosis; HIV; HBV; Mitophagy; Antibiotic; Bacterial; Fluorescent Dye
-
Research Areas: Cancer
-
target: Monocarboxylate TransporterResearch Areas: Cancer
-
target: GlutaminaseResearch Areas: Cancer
-
target: Monocarboxylate TransporterResearch Areas: Others